Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

NCT06277427 is registered in ClinicalTrials.gov with Lingli Dong as lead sponsor.

NCT NCT06277427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
Lead sponsor
Lingli Dong
Phase
Not applicable
Overall status
Recruiting
Start date
February 5, 2024
Completion date
January 31, 2027
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anca associated vasculitis, lupus nephritis